Amneal Pharmaceuticals, Inc. AMRX Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s intangible purchases?
- Amneal Pharmaceuticals, Inc. (AMRX) reported intangible purchases of $7.85M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s intangible purchases changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s intangible purchases increased by 86.9% year-over-year, from $4.2M to $7.85M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s intangible purchases?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s intangible purchases has grown at a 73.8% compound annual growth rate (CAGR), from $1.7M to $15.51M.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.